In this meta-analysis, results show that GSTP1 IIe105Val IIe/Val and Val/Val genotypic Asian NSCLC patients were more likely to have better response rates compared to GSTP1 IIe105Val IIe/IIe patients. Here, GSTP1 is linked to non-small cell lung carcinoma.